Loading clinical trials...
Loading clinical trials...
The goal of this study is to develop an optimized intervention for reducing leisure sedentary screen time (SST) in middle-aged adults with overweight or obesity. Investigators will use the multiphase optimization (MOST) framework to conduct a highly efficient full-factorial experimental study to simultaneously test the main effects for each of three intervention components (LOCKOUT, TEXT, EARN) and their interactions (e.g., TEXT+EARN; LOCKOUT+EARN+TEXT) over 16 weeks.
Primary Aim: To identify which component(s) from three components under consideration for inclusion in StandUPTV reduce SST by \>60 min per day per day at 16 weeks. The three components tested will be: (a) LOCKOUT (no vs. yes); (b) TEXT (no vs. yes); and (c) EARN (no vs. yes). The investigators will use a highly efficient experimental strategy to detect effects of individual components as well as all two- and three-way interactions. The secondary aim of this study is to examine how reductions in SST displace time into other active behaviors, i.e., light-intensity physical activity (LPA), moderate-to vigorous physical activity (MVPA) and activity type (e.g., housework, walking, exercise behaviors). The investigators will use both device-based (activPAL3c) and self-report (ACT24) measures to understand whether SST displacement can increase active behaviors, particularly MVPA.
Age
23 - 64 years
Sex
ALL
Healthy Volunteers
Yes
Arizona State University
Tempe, Arizona, United States
California Polytechnic University San Luis Obispo
San Luis Obispo, California, United States
Start Date
June 21, 2021
Primary Completion Date
September 30, 2023
Completion Date
September 30, 2023
Last Updated
April 15, 2025
110
ACTUAL participants
Device-based feedback, self-monitoring, and education: CORE
BEHAVIORAL
Sedentary Screen Time lockout: LOCKOUT
BEHAVIORAL
Context-based prompts: TEXT
BEHAVIORAL
Earn sedentary screen time through moderate-vigorous physical activity: EARN
BEHAVIORAL
Lead Sponsor
Arizona State University
Collaborators
NCT06359210
NCT07140770
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions